Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Requests approaching 50,000 annually for emergency drug release program

A Robinson

    CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
    |September 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Postpartum femoral neuropathy: more common than you think.

    Anaesthesia·2000
    Same author

    Search for scalar top and scalar bottom quarks in pp collisions at square root s=1.8 TeV.

    Physical review letters·2000
    Same author

    Search for a W' boson via the decay mode W'-->munumu in 1.8 TeV pp collisions.

    Physical review letters·2000
    Same author

    Mining for putative regulatory elements in the yeast genome using gene expression data.

    Proceedings. International Conference on Intelligent Systems for Molecular Biology·2000
    Same author

    Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness.

    Health technology assessment (Winchester, England)·2000
    Same author

    The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase activity.

    The Journal of biological chemistry·2000

    Health Canada's Emergency Drug Release Program, despite its name, rarely handles emergencies. Physicians find the extensive paperwork burdensome for acquiring unmarketed medications for patients with serious illnesses like HIV and AIDS.

    Area of Science:

    • Health Policy
    • Pharmaceutical Access
    • Drug Regulation

    Background:

    • Health Canada's Emergency Drug Release Program facilitates access to unmarketed drugs for severe conditions.
    • The program manages approximately 44,000 requests annually for patients with HIV infection, AIDS, and other serious illnesses.

    Purpose of the Study:

    • To evaluate the operational efficiency and appropriateness of the Emergency Drug Release Program.
    • To address physician concerns regarding the program's administrative burden and naming convention.

    Main Methods:

    • Analysis of program request data and operational procedures.
    • Qualitative feedback from healthcare providers utilizing the program.

    Main Results:

    Related Experiment Videos

  • The majority of requests are not for medical emergencies, contradicting the program's name.
  • Physicians report significant administrative burden due to extensive paperwork requirements.

    • Conclusions:

    • The Emergency Drug Release Program's name is a misnomer, as few requests are urgent.
    • There is a need to streamline administrative processes to reduce the labor-intensive nature of the program for physicians.